T1	Participants 58 92	patients with multivessel disease.
T2	Participants 327 365	patients with coronary artery disease.
T3	Participants 408 464	patients with multivessel disease suitable for treatment
T4	Participants 590 623	Patients with multivessel disease
T5	Participants 1669 1750	diabetic patients who were being treated with insulin or oral hypoglycemic agents